Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIENOR: Bevacizumab and Paclitaxel for Relapsed Ovarian Sex-cord Stromal Tumors
NCT01770301Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Feb 2013
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Ovarian sex-cord stromal tumor (SCST), sponsored by ARCAGY. Started Feb 2013; status: completed.
02
Drugs
bevacizumab
03
Conditions
Ovarian sex-cord stromal tumor (SCST)
Beyond the preview
Go deeper on NCT01770301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01770301.